Detalhe da pesquisa
1.
Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study.
Respir Res
; 23(1): 114, 2022 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35509077
2.
First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults.
Clin Infect Dis
; 70(10): 2073-2081, 2020 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340042
3.
Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.
J Infect Dis
; 219(11): 1799-1803, 2019 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30715452
4.
Impact of adjuvants on CD4(+) T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial.
Clin Immunol
; 169: 16-27, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27236001
5.
A randomized, controlled dose-finding Phase II study of the M72/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults.
J Clin Immunol
; 33(8): 1360-75, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24142232
6.
Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-É£ Enzyme-Linked ImmunoSpot (ELISpot) protocols.
J Immunol Methods
; 523: 113584, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37918618
7.
T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults.
Front Immunol
; 14: 1260146, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936699
8.
Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium.
Front Immunol
; 13: 982887, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36341380
9.
An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteers.
Clin Infect Dis
; 52(4): 522-31, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21208909
10.
Whole blood can be used as an alternative to isolated peripheral blood mononuclear cells to measure in vitro specific T-cell responses in human samples.
J Immunol Methods
; 492: 112940, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493551
11.
Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants.
NPJ Vaccines
; 6(1): 78, 2021 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021167
12.
Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months.
Eur J Pediatr
; 169(8): 925-33, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20148263
13.
Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01B vaccination.
Vaccine
; 38(7): 1678-1689, 2020 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31932137
14.
Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans.
Front Immunol
; 8: 943, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28855902
15.
Impact and Lessons Learned from Mass Drug Administrations of Malaria Chemoprevention during the Ebola Outbreak in Monrovia, Liberia, 2014.
PLoS One
; 11(8): e0161311, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27580098
16.
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
Vaccine
; 33(8): 1084-91, 2015 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25444781
17.
Immunogenicity and safety of a booster dose of an investigational adjuvanted polyprotein HIV-1 vaccine in healthy adults and effect of administration of chloroquine.
Clin Vaccine Immunol
; 21(3): 302-11, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24391139
18.
Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.
Vaccine
; 32(22): 2657-65, 2014 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24144472
19.
Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients.
J Immunol Methods
; 414: 1-10, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25224748
20.
Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.
J Acquir Immune Defic Syndr
; 59(1): 1-9, 2012 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21963936